Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Compounds targeting OSBPL7 increase ABCA1-dependent cholesterol efflux preserving kidney function in two models of kidney disease.

Nature communications·2021
Same author

Pioglitazone Ameliorates Gentamicin Ototoxicity by Affecting the TLR and STAT Pathways in the Early Postnatal Organ of Corti.

Frontiers in cellular neuroscience·2020
Same author

Dual PPARα/γ agonist aleglitazar confers stroke protection in a model of mild focal brain ischemia in mice.

Journal of molecular medicine (Berlin, Germany)·2019
Same author

Insulin Receptor and Glucose Transporters in the Mammalian Cochlea.

Audiology & neuro-otology·2019
Same author

Pioglitazone Represents an Effective Therapeutic Target in Preventing Oxidative/Inflammatory Cochlear Damage Induced by Noise Exposure.

Frontiers in pharmacology·2018
Same author

Effects of peroxisome proliferator activated receptors (PPAR)-γ and -α agonists on cochlear protection from oxidative stress.

PloS one·2017
Same journal

Microreactors for continuous processing – How close to commercial utility?

Current opinion in drug discovery & development·2010
Same journal

Synthesis of polyketide natural products and analogs as promising anticancer agents.

Current opinion in drug discovery & development·2010
Same journal

Enantioselective synthesis of substituted oxindoles and spirooxindoles with applications in drug discovery.

Current opinion in drug discovery & development·2010
Same journal

Eliminating pharmaceutical impurities: Recent advances in detection techniques.

Current opinion in drug discovery & development·2010
Same journal

Stereoselective heterocycle synthesis through oxidative carbon-hydrogen bond activation.

Current opinion in drug discovery & development·2010
Same journal

Catalysis in aqueous media for the synthesis of drug-like molecules.

Current opinion in drug discovery & development·2010
See all related articles

Related Experiment Video

Updated: Jun 11, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

Recent progress in liver X receptor-selective modulators.

Hassen Ratni1, Matthew B Wright

  • 1F Hoffmann-La Roche Ltd, Basel, Switzerland. hasane.ratni@roche.com

Current Opinion in Drug Discovery & Development
|July 3, 2010
PubMed
Summary
This summary is machine-generated.

Developing safer liver X receptor (LXR) modulators is crucial for treating atherosclerosis. This review explores medicinal chemistry strategies to create effective LXR drugs with improved therapeutic benefits and fewer side effects.

Related Experiment Videos

Last Updated: Jun 11, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

Area of Science:

  • Biochemistry
  • Pharmacology
  • Medicinal Chemistry

Background:

  • Liver X receptors (LXRs), LXRalpha and LXRbeta, are key regulators of cholesterol metabolism and HDL formation, offering atheroprotective effects.
  • However, LXRs also influence lipogenesis and can cause hypertriglyceridemia, posing challenges for drug development.
  • Designing effective LXR modulators without adverse effects remains a significant hurdle in pharmaceutical research.

Purpose of the Study:

  • To review current medicinal chemistry strategies for developing novel liver X receptor (LXR) modulators.
  • To explore approaches for enhancing therapeutic utility and safety profiles of LXR-targeting drugs.
  • To summarize the clinical development status of promising LXR modulator compounds.

Main Methods:

  • Analysis of X-ray structures of LXR protein/small-molecule complexes to understand ligand-binding pocket characteristics.
  • Review of medicinal chemistry literature focusing on the design of LXR modulators.
  • Summarization of data from compounds that have advanced into clinical trials.

Main Results:

  • LXR ligand-binding pockets are large and flexible, enabling the design of diverse ligands with varied selectivity.
  • Medicinal chemistry efforts focus on balancing LXR's beneficial cholesterol efflux effects with its lipogenic impacts.
  • Several LXR modulators have progressed into clinical development, indicating therapeutic potential.

Conclusions:

  • Novel medicinal chemistry strategies are yielding LXR modulators with improved therapeutic potential and safety.
  • Continued research into LXR modulation is vital for addressing metabolic and cardiovascular diseases.
  • Understanding LXR structure-activity relationships is key to optimizing drug design for atherosclerosis treatment.